Chun-Jung Tsai Biography and Net Worth

Director of Ainos


Mr. Tsai has served as a Director of the Company since April 2021. He is also a manager of the Company’s sales team. He has served as a director of Ainos Inc. (Cayman Islands) since 2019, a director of AI Nose Corporation since March 2016, and a director of Taiwan Carbon Nano Technology Corporation (TCNT) since July 2012.

What is Chun-Jung Tsai's net worth?

The estimated net worth of Chun-Jung Tsai is at least $849.08 thousand as of May 26th, 2026. Mr. Tsai owns 658,199 shares of Ainos stock worth more than $849,077 as of October 7th. This net worth evaluation does not reflect any other assets that Mr. Tsai may own. Learn More about Chun-Jung Tsai's net worth.

How do I contact Chun-Jung Tsai?

The corporate mailing address for Mr. Tsai and other Ainos executives is 3050 Post Oak Blvd,, Suite 510-t80, Houston, TX, 77056. Ainos can also be reached via phone at (281) 898-6586 and via email at [email protected]. Learn More on Chun-Jung Tsai's contact information.

Has Chun-Jung Tsai been buying or selling shares of Ainos?

Chun-Jung Tsai has not been actively trading shares of Ainos within the last three months. Most recently, Chun-Jung Tsai sold 27,718 shares of the business's stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $1.87, for a transaction totalling $51,832.66. Following the completion of the sale, the director now directly owns 658,199 shares of the company's stock, valued at $1,230,832.13. Learn More on Chun-Jung Tsai's trading history.

Are insiders buying or selling shares of Ainos?

During the last year, Ainos insiders bought shares 5 times. They purchased a total of 7,800 shares worth more than $15,946.00. During the last year, insiders at the sold shares 7 times. They sold a total of 227,069 shares worth more than $461,398.62. The most recent insider tranaction occured on June, 5th when Director Yao-Chung Chiang bought 3,500 shares worth more than $7,175.00. Insiders at Ainos own 9.8% of the company. Learn More about insider trades at Ainos.

Information on this page was last updated on 6/5/2026.

Chun-Jung Tsai Insider Trading History at Ainos

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2026Sell27,718$1.87$51,832.66658,199View SEC Filing Icon  
5/22/2026Sell1,082$1.55$1,677.10685,917View SEC Filing Icon  
6/27/2025Sell2,000$2.50$5,000.00276,999View SEC Filing Icon  
6/25/2025Sell1,400$2.50$3,500.00278,999View SEC Filing Icon  
6/23/2025Sell2,000$2.50$5,000.00280,399View SEC Filing Icon  
6/19/2025Sell2,180$2.75$5,995.00282,399View SEC Filing Icon  
6/18/2025Sell1,000$2.60$2,600.00284,580View SEC Filing Icon  
See Full Table

Chun-Jung Tsai Buying and Selling Activity at Ainos

This chart shows Chun-Jung Tsai's buying and selling at Ainos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ainos Company Overview

Ainos logo
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
Read More

Today's Range

Now: $1.24
Low: $1.23
High: $1.28

50 Day Range

MA: $1.42
Low: $1.24
High: $1.60

2 Week Range

Now: $1.24
Low: $1.20
High: $4.44

Volume

16,521 shs

Average Volume

387,915 shs

Market Capitalization

$9.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.47